版本:
中国

BRIEF-Inovio begins phase 3 clinical trial of VGX-3100

June 8 Inovio Pharmaceuticals Inc

* Inovio begins phase 3 clinical trial of VGX-3100 for the treatment of HPV-related cervical pre-cancer

* Plans to immediately begin recruiting patients for phase 3 trial

* Pivotal data from program will support potential licensure of VGX-3100 as first immunotherapy for this disease​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐